Vitiligo | Incyte | INCB18424-308
Pharmaceutical Company/Sponsor:
Incyte
Code:
INCB18424-308
Title:
A Double-Blind, Vehicle-Controlled, Randomized Withdrawal and Treatment Extension Study to Assess the Long-Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo
Type:
Interventional
Phase:
3
Condition/Disease:
Vitiligo
Intervention(s)/Treatment(s):
Drug: Ruxolitinib cream
Drug: Vehicle
Status:
Recruiting
Link for Additional Information:
